Standout Papers

Comparison of C-Reactive Protein and Low-Density Lipoprot... 1987 2026 2000 2013 2.7k
  1. Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events (2002)
    Paul M. Ridker, Nader Rifai et al. New England Journal of Medicine
  2. Atherosclerosis (2019)
    Peter Libby, Julie E. Buring et al. Nature Reviews Disease Primers
  3. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events (2003)
    Paul M. Ridker, Julie E. Buring et al. Circulation
  4. Epidemiology in Medicine (1987)
    Charles H. Hennekens, Julie E. Buring et al. The International Islamic University Malaysia Repository (The International Islamic University Malaysia)
  5. A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women (2005)
    Paul M. Ridker, Nancy R. Cook et al. New England Journal of Medicine
  6. Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women (1998)
    Paul M. Ridker, Julie E. Buring et al. Circulation
  7. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women (2007)
    Paul M. Ridker, Julie E. Buring et al. JAMA
  8. Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women (2007)
    Sandeep Bansal, Julie E. Buring et al. JAMA
  9. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (2018)
    JoAnn E. Manson, Nancy R. Cook et al. New England Journal of Medicine
  10. Prevalence of dry eye syndrome among US women (2003)
    Debra A. Schaumberg, David A. Sullivan et al. American Journal of Ophthalmology
  11. Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer (2005)
    I‐Min Lee, Nancy R. Cook et al. JAMA
  12. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) (2007)
    Nancy R. Cook, Jeffrey A. Cutler et al. BMJ
  13. A Prospective Evaluation of an Angiotensin-Converting–Enzyme Gene Polymorphism and the Risk of Ischemic Heart Disease (1995)
    Klaus Lindpaintner, Marc A. Pfeffer et al. New England Journal of Medicine
  14. Physical Activity and Reduced Risk of Cardiovascular Events (2007)
    Samia Mora, Nancy R. Cook et al. Circulation
  15. Cardiovascular Disease in Women (2016)
    Mariana García, Sharon L. Mulvagh et al. Circulation Research
  16. Fruit and vegetable intake and risk of cardiovascular disease: the Women’s Health Study (2000)
    Simin Liu, JoAnn E. Manson et al. American Journal of Clinical Nutrition
  17. Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (2018)
    JoAnn E. Manson, Nancy R. Cook et al. New England Journal of Medicine
  18. Low-Dose Aspirin in the Primary Prevention of Cancer (2005)
    Nancy R. Cook, I‐Min Lee et al. JAMA
  19. Non–HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women (2005)
    Paul M. Ridker, Nader Rifai et al. JAMA
  20. Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men (2009)
    Eric L. Ding, Yiqing Song et al. New England Journal of Medicine
  21. The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease (2011)
    JoAnn E. Manson, Shari S. Bassuk et al. Contemporary Clinical Trials
  22. Association of Step Volume and Intensity With All-Cause Mortality in Older Women (2019)
    I‐Min Lee, Eric J. Shiroma et al. JAMA Internal Medicine
  23. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults (2022)
    Meryl S. LeBoff, Sharon H. Chou et al. New England Journal of Medicine
  24. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women (2024)
    Paul M. Ridker, M. Vinayaga Moorthy et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 115 standout
Sub-graph 1 of 14

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
91 intermediate papers

Works of Julie E. Buring being referenced

Atherosclerosis
2019 Standout
Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy
2008
and 46 more

Author Peers

Author Last Decade Papers Cites
Julie E. Buring 15309 12230 12151 596 64.0k
Charles H. Hennekens 18066 16749 17141 577 83.9k
Aaron R. Folsom 26297 10446 10042 859 73.5k
Lewis H. Kuller 19039 9559 15696 999 76.0k
Nancy R. Cook 13829 8741 6621 432 49.4k
Diederick E. Grobbee 17961 7330 11946 926 62.4k
Jiang He 23109 10938 12227 832 59.8k
Frank M. Sacks 14944 18309 14975 410 61.0k
Andrew S. Levey 30240 7637 13235 503 121.9k
Mark Woodward 18496 9844 14717 983 63.2k
Josef Coresh 29995 7447 16406 936 112.1k

All Works

Loading papers...

Rankless by CCL
2026